Bafna Pharmaceuticals informs about PCS certificate

11 Apr 2022 Evaluate
Bafna Pharmaceuticals has informed that it enclosed certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

74.90 1.90 (2.60%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...